ALDEYRA THERAPEUTICS, INC. Shareholders' Equity
ALDEYRA THERAPEUTICS, INC. (ALDX) had Shareholders' Equity of $37.89 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-06
- 2026-06-30: Stockholders' Equity Attributable to Parent $37.89M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $42.16M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $44.25M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $49.24M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $37.89M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $42.16M 10-Q · filed 2026-08-06 | |
| 2025-12-31 | $44.25M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $49.24M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $55.29M 10-Q · filed 2026-08-06 | |
| 2025-03-31 | $63.60M 10-Q · filed 2026-08-06 | |
| 2024-12-31 | $71.00M 10-Q · filed 2026-08-06 | |
| 2024-09-30 | $85.10M 10-Q · filed 2025-11-05 | |
| 2024-06-30 | $98.31M 10-Q · filed 2025-11-05 | |
| 2024-03-31 | $113.42M 10-Q · filed 2025-08-07 | |
| 2023-12-31 | $119.80M 10-K · filed 2026-02-27 | |
| 2023-09-30 | $123.01M 10-Q · filed 2024-11-07 | |
| 2023-06-30 | $129.88M 10-Q · filed 2024-11-07 | |
| 2023-03-31 | $137.24M 10-Q · filed 2024-08-01 | |
| 2022-12-31 | $151.01M 10-K · filed 2025-02-28 | |
| 2022-09-30 | $162.19M 10-Q · filed 2023-11-03 | |
| 2022-06-30 | $174.03M 10-Q · filed 2023-11-03 | |
| 2022-03-31 | $190.69M 10-Q · filed 2023-08-03 | |
| 2021-12-31 | $205.74M 10-K · filed 2024-03-07 | |
| 2021-09-30 | $219.67M 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $233.68M 10-Q · filed 2022-11-10 | |
| 2021-03-31 | $126.07M 10-Q · filed 2022-08-05 | |
| 2020-12-31 | $59.51M 10-K · filed 2023-03-09 | |
| 2020-09-30 | $69.17M 10-Q · filed 2021-10-28 | |
| 2020-06-30 | $52.79M 10-Q · filed 2021-10-28 | |
| 2020-03-31 | $43.47M 10-Q · filed 2021-08-05 | |
| 2019-12-31 | $48.08M 10-K · filed 2022-03-17 | |
| 2019-09-30 | $50.88M 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $67.33M 10-Q · filed 2020-11-05 | |
| 2019-03-31 | $78.48M 10-Q · filed 2020-08-06 | |
| 2018-12-31 | $86.62M 10-K · filed 2021-03-11 | |
| 2018-09-30 | $28.60M 10-Q · filed 2019-11-07 | |
| 2018-06-30 | $36.98M 10-Q · filed 2019-11-07 | |
| 2018-03-31 | $36.00M 10-Q · filed 2019-08-09 | $36.00M 10-Q · filed 2018-05-15 |
| 2017-12-31 | $39.60M 10-K · filed 2020-03-12 | |
| 2017-09-30 | $45.90M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $23.34M 10-Q · filed 2017-08-07 | |
| 2017-03-31 | $28.00M 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $21.65M 10-K · filed 2019-03-08 | |
| 2016-09-30 | $25.67M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $29.52M 10-Q · filed 2016-08-10 | |
| 2016-03-31 | $20.53M 10-Q · filed 2016-05-09 | |
| 2016-01-01 | $24.88M 10-K · filed 2018-03-29 | |
| 2015-12-31 | $24.88M 10-K · filed 2017-03-30 | |
| 2015-09-30 | $28.70M 10-Q · filed 2015-11-13 | |
| 2015-06-30 | $31.52M 10-Q · filed 2015-08-14 | |
| 2015-03-31 | $13.83M 10-Q · filed 2015-05-14 | |
| 2014-12-31 | $6.28M 10-K · filed 2017-03-30 | |
| 2014-09-30 | $8.26M 10-Q · filed 2014-11-12 | |
| 2014-06-30 | $9.81M 10-Q · filed 2014-08-07 | |
| 2014-03-31 | -$39.65M 10-Q · filed 2014-06-11 | |
| 2013-12-31 | -$40.22M 10-K · filed 2016-03-30 | |
| 2012-12-31 | -$54.38M 10-K · filed 2015-03-23 | |
| 2011-12-31 | -$15.51M 10-Q · filed 2014-06-11 | |
| 2010-12-31 | -$12.97M 10-Q · filed 2014-06-11 | |
| 2009-12-31 | -$9.21M 10-Q · filed 2014-06-11 | |
| 2008-12-31 | -$4.06M 10-Q · filed 2014-06-11 | |
| 2007-12-31 | -$1.85M 10-Q · filed 2014-06-11 | |
| 2006-12-31 | -$1.32M 10-Q · filed 2014-06-11 | |
| 2005-12-31 | -$385.21K 10-Q · filed 2014-06-11 | |
| 2004-12-31 | $947.00 10-Q · filed 2014-06-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |